Black Friday Deal | Save up to $20. Get the code »

Antibodies: Volume 2: Novel Technologies and Therapeutic Use

by

Write The First Customer Review

It is now over one hundred years since von Behring and Kitsato first concluded experiments that led to the use of passive immunisation, employing antibodies raised in animals against tetanus and diphtheria toxins. The advancement of technology both in manufacturing purity product in a cost effective way and the clinical research has proved that antibodies are one ofthe most successful products in biotechnology. Monoclonal antibodies account for between one-third and one-halfof all pharmaceutical products in development and ...

Antibodies: Volume 2: Novel Technologies and Therapeutic Use 2012, Springer

ISBN-13: 9781461347026

Softcover Reprint of the Origi edition

Trade paperback

Select
Antibodies: Volume 2: Novel Technologies and Therapeutic Use 2004, Springer, New York, NY

ISBN-13: 9780306483158

2004 edition

Hardcover

Select